| Year |
Citation |
Score |
| 2012 |
Féher J, Lengyel G. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology. 13: 210-7. PMID 21466434 DOI: 10.2174/138920112798868818 |
0.348 |
|
| 2010 |
Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, et al. Pathological aspects of lipid peroxidation. Free Radical Research. 44: 1125-71. PMID 20836660 DOI: 10.3109/10715762.2010.498478 |
0.315 |
|
| 2010 |
Fehér J, Lengyel G. [Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orvosi Hetilap. 151: 933-40. PMID 20494888 DOI: 10.1556/Oh.2010.28900 |
0.329 |
|
| 2008 |
Fehér J, Lengyel G. [Silymarin in the treatment of chronic liver diseases: past and future]. Orvosi Hetilap. 149: 2413-8. PMID 19073452 DOI: 10.1556/Oh.2008.28519 |
0.34 |
|
| 2008 |
Hagymási K, Lengyel G, Nagy E, Pallai Z, Kocsis I, Fehér J, Tulassay Z, Blázovics A. Impaired Antioxidant Status in Non-Organ Specific Autoantibody Positive Patients with Non-Alcoholic Fatty Liver Disease Hungarian Medical Journal. 2: 563-570. DOI: 10.1556/Hmj.2.2008.4.7 |
0.315 |
|
| 2007 |
Eiszrich A, Fehér J. [Fatty liver in childhood]. Orvosi Hetilap. 148: 2461-8. PMID 18079093 DOI: 10.1556/Oh.2007.28270 |
0.313 |
|
| 2007 |
Nemes B, Sárváry E, Gerlei Z, Fazakas J, Doros A, Németh A, Görög D, Fehérvári I, Máthé Z, Gálffy Z, Pár A, Schuller J, Telegdy L, Fehér J, Lotz G, et al. [The recurrence of hepatitis C virus after liver transplantation]. Orvosi Hetilap. 148: 1971-9. PMID 17932003 DOI: 10.1556/Oh.2007.28176 |
0.523 |
|
| 2007 |
Lelbach A, Muzes G, Feher J. Current perspectives of catabolic mediators of cancer cachexia. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 13: RA168-173. PMID 17767131 |
0.734 |
|
| 2007 |
Székely E, Tasnádi G, Szentmihályi K, Almási A, Bor M, Fehér J, Blázovics A. [Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda]. Orvosi Hetilap. 148: 1095-100. PMID 17545118 DOI: 10.1556/Oh.2007.28103 |
0.31 |
|
| 2007 |
Fraenkel E, Takács R, Hamvas J, Lengyel G, Fehér J. [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. Orvosi Hetilap. 148: 793-8. PMID 17452309 DOI: 10.1556/Oh.2007.28049 |
0.305 |
|
| 2006 |
Lelbach A, Fehér J, Székács B. [The molecular biology of aging--therapeutic interventions?]. Orvosi Hetilap. 147: 441-8. PMID 16573173 |
0.717 |
|
| 2005 |
Lelbach A, Muzes G, Feher J. The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases. Acta Physiologica Hungarica. 92: 97-107. PMID 16268048 DOI: 10.1556/Aphysiol.92.2005.2.1 |
0.706 |
|
| 2005 |
Nemes B, Kóbori L, Gálffy Z, Lengyel G, Doros A, Sárváry E, Perner F, Schaff Z, Fazakas J, Szalay F, Féher J, Járay J. [Clinical factors influencing the complications and survival of liver transplantation in Hungary]. Orvosi Hetilap. 146: 1567-74. PMID 16136733 |
0.455 |
|
| 2004 |
Lelbach A, Muzes G, Feheŕ J. [Molecular mechanisms of cancer cachexia]. Orvosi Hetilap. 145: 2329-34. PMID 16106904 |
0.724 |
|
| 2003 |
Lengyel G, Kóbori L, Fehérvári I, Nemes B, Görög D, Patonai A, Sárváry E, Varga M, Perner F, Fehér J. [Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation]. Orvosi Hetilap. 144: 2367-70. PMID 14753031 |
0.479 |
|
| 2003 |
Kóbori L, Sárváry E, Nemes B, Lakatos M, Fehérvári I, Görög D, Dallos G, Gerlei Z, Fazakas J, Tóth T, Lengyel G, Fehér J, Járay J. [The role of oxidative stress and arterial blood supply in the transplanted liver function]. Orvosi Hetilap. 144: 2219-23. PMID 14686007 |
0.457 |
|
| 1998 |
Fehér J, Lengyel G, Blázovics A. Oxidative stress in the liver and biliary tract diseases. Scandinavian Journal of Gastroenterology. 33: 38-46. PMID 9867111 DOI: 10.1080/003655298750026543 |
0.31 |
|
| 1987 |
Fehér J, Láng I, Nékám K, Csomós G, Müzes G, Deák G. Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease. Free Radical Research. 3: 373-377. PMID 3508451 DOI: 10.3109/10715768709088078 |
0.304 |
|
| Show low-probability matches. |